0001415889-22-008799.txt : 20220817 0001415889-22-008799.hdr.sgml : 20220817 20220817181543 ACCESSION NUMBER: 0001415889-22-008799 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220815 FILED AS OF DATE: 20220817 DATE AS OF CHANGE: 20220817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Geist William CENTRAL INDEX KEY: 0001832210 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 221175699 MAIL ADDRESS: STREET 1: 900 MIDDLESEX TURNPIKE STREET 2: C/O QUANTERIX CORPORATION CITY: BILLERICA STATE: MA ZIP: 01821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 form4-08172022_030831.xml X0306 4 2022-08-15 0000842023 BIO-TECHNE Corp TECH 0001832210 Geist William 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 false true false false PRESIDENT, PROTEIN SCIENCES Common Stock 2490 D Restricted Stock Units 2022-08-15 4 A 0 1785 0 A Common Stock 1785 1785 D Stock Options (Right to Buy) 378.08 2022-08-15 4 A 0 5550 0 A 2029-08-15 Common Stock 5550 5550 D Stock Options (Right to Buy) 378.08 2022-08-15 4 A 0 7400 0 A 2029-08-15 Common Stock 7400 7400 D Restricted Stock Units Common Stock 840 840 D Stock Options (Right to Buy) 401.57 2029-02-01 Common Stock 2984 2984 D Stock Options (Right to Buy) 401.57 2029-02-01 Common Stock 3978 3978 D Represents 2,490 shares of restricted stock for which the risk of forfeiture will lapse as to 830 shares on each of February 1, 2023, February 1, 2024 and February 1, 2025. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 1,850 shares vest on each of 8/15/2023, 8/15/2024, 8/51/2025 and 8/15/2026. Options to purchase 995 shares vest on each of 2/1/2023 and 2/1/2024 and options to purchase 994 shares vest on each of 2/1/2025 and 2/1/2026. /s/ Brenda S. Furlow as Attorney-in-Fact for William Geist pursuant to Power of Attorney previously filed 2022-08-17